Resolution of Thyroid Acropachy in a Patient Treated With Teprotumumab: A Case Report and Review of Mechanisms [PDF]
Case Reports in EndocrinologyGraves’ disease is an autoimmune thyroidopathy associated with hyperthyroidism and nonendocrine manifestations such as thyroid eye disease (TED), pretibial myxedema, and thyroid acropachy.
Soumya Chatterjee
doaj +3 more sources
Local immune microenvironment of skin may play an important role in the development of pretibial myxedema [PDF]
Experimental Dermatology, 2021 Abstract Pretibial myxedema (PTM), characterized by the accumulation of glycosaminoglycans in dermis is an autoimmune skin disorder, which is almost always associated with Graves’ disease (GD). Although fibroblast stimulated by thyroid‐stimulating hormone receptor (TSHR) antibody, cytokines and growth factors have been postulated as target of the ...
Xiaoying Chen +2 more
exaly +3 more sources
Identifying the potential origin of mucin in primary cutaneous mucinoses: A retrospective study and analysis using histopathology and multiplex fluorescence staining [PDF]
Journal of the European Academy of Dermatology and Venereology, Volume 37, Issue 7, Page 1302-1310, July 2023., 2023 Background: Primary cutaneous mucinoses (PCM) are rare diseases characterized by dermal or follicular mucin deposits. Objectives: A retrospective study characterizing PCM to compare dermal with follicular mucin to identify its potential origin on a ...
Cheng, Phil Fang +6 more
core +2 more sources
Henoch–Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis
Case Reports in Endocrinology, 2021 Graves’ disease is the most common cause of hyperthyroidism, which is characterized by thyroid antibodies and the following clinical manifestations: goiter, ophthalmopathy, and pretibial myxedema.
Mojgan Sanjari +2 more
doaj +2 more sources
Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema [PDF]
Dermatopathology, 2016 Background: Hyaluronidases are essential for the breakdown of hyaluronate (HA) in tissues and may be used to prevent the adverse effects of HA fillers.
Sébastien Menzinger +3 more
doaj +2 more sources
Treatment of pretibial myxedema with intralesional immunomodulating therapy [PDF]
Therapeutics and Clinical Risk Management, 2017 Ziwei Ren,1,* Min He,2,* Fang Deng,2 Yan Chen,1 Liyin Chai,1 Bing Chen,2 Wuquan Deng1 1Department of Endocrinology and Nephrology, Chongqing Emergency Medical Hospital (The Fourth People’s Hospital of Chongqing), 2Department of Endocrinology ...
Ren Z +6 more
doaj +2 more sources
Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases [PDF]
J Thyroid Res, 2016 Background. Pretibial myxedema (PTM) is a rare dermopathy. The morphologic features and mechanism of its evolving process are not reported in large case series.Methods.
Changgui Lan +4 more
core +3 more sources
An atypical presentation of pretibial myxedema in a euthyroid patient with absent antithyroid autoantibodies [PDF]
JAAD Case Reports, 2021 Derek Beaulieu, MD, Kristin Nord, MD
doaj +2 more sources
Graves’ Dermopathy: Responsive with Intralesion Steroid [PDF]
Acta Medica Indonesiana, 2016 A 51-year-old male came with thickening lesion in both legs since 2.5 years before presented. It started with small lesion and went larger. Before diagnosed, he was admitted to hospital due to unresolved headache.
Tri Juli E Tarigan +2 more
doaj +4 more sources
Pretibial myxedema in a euthyroid patient [PDF]
Hormones, 2018 Pretibial myxedema (PM) is a rare extrathyroidal manifestation of Graves' disease (GD), usually during the hyperthyroid state, coexisting with orbitopathy. We describe a rare case of a biopsy-proven PM in a euthyroid patient, without history of GD or Hashimoto's thyroiditis.
Panagiotis Anagnostis +1 more
exaly +4 more sources